MichaelCraigStilesMD

Ophthalmology • Overland Park, KS

Anterior Segment Related, Glaucoma Related, Retinal Disease

Medical Director/ Stiles Eyecare Excellence and Glaucoma Institute

Join to view full profile

Dr. Stiles is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stiles' full profile

Already have an account?

Office
7200 W 129th St
Overland Park, KS 66213
Phone+1 913-897-9299

Fax+1 913-897-3031

Education & Training

University of Kansas School of MedicineInternship, Internal Medicine, 2010 - 2011
University of Kansas School of MedicineResidency, Ophthalmology, 2011
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Surgical Retina and Vitreous, 1990
University of Kansas School of MedicineResidency, Ophthalmology, 1986 - 1989
University of Kansas (Wichita)Internship, Internal Medicine, 1985 - 1986
University of Kansas School of MedicineClass of 1985
University of Notre DameBS, Science Preprofessional, 1977 - 1981

Certifications & Licensure

KS State Medical License 1986 - 2025
MO State Medical License 1990 - 2025
PA State Medical License 1989 - 1990
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Medflow EHR, Medflow, Inc., 2012-2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma Start of enrollment: 2010 May 01
Completed
Phase 1, Phase 2
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery Start of enrollment: 2012 Jan 16
Completed
Not Applicable
InnFocus MicroShunt Versus Trabeculectomy Study Start of enrollment: 2015 Dec 15
Completed
Not Applicable
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease Start of enrollment: 2016 Jun 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

160 citations
Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
Thomas W. Samuelson, Steven R. Sarkisian, David M. Lubeck, Michael C. Stiles, Yi-Jing Duh
Ophthalmology. 2019-03-14
93 citations
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
N. Douglas Baker, Howard S. Barnebey, Marlene R. Moster, Michael C Stiles, Steven D. Vold
Ophthalmology. 2021-05-27
113 citations
Ab interno trabeculectomy: Outcomes in exfoliation versus primary open-angle glaucoma
Jessica L.M. Ting, Karim F. Damji, Michael C. Stiles
Journal of Cataract and Refractive Surgery. 2012-02-01

Press Mentions

Michael C. Stiles, MD, Ophthalmologist with Stiles Eyecare ExcellenceSeptember 21st, 2019
$Multiple Surgeon Presentations to Include Glaukos Technologies at 2018 American Society of Cataract and Refractive Surgery$
Multiple Surgeon Presentations to Include Glaukos Technologies at 2018 American Society of Cataract and Refractive SurgeryApril 11th, 2018
First-Line Treatment: SLT or Medication?April 9th, 2024

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow